ABCG2 and metabolic dysfunction-associated steatotic liver disease: Among all subjects, a final constructed model using a stepwise method (probability to enter ≤0.05; to remove ≥0.10), found age (β = −0.11, 95% CI −0.16 to −0.06), WC (β = 0.17, 95% CI 0.11–0.23), NAFLD (β = 0.15, 95% CI 0.09–0.21), log-transformed serum creatinine (β = 0.29, 95% CI, 0.24–0.34) and triglycerides (β = 0.11, 95% CI 0.05–0.16), as well as the Q141K variant in ABCG2 gene (β = 0.12, 95% CI 0.07–0.17) as significant predictors (all P<0.001) of the logarithm of SUA levels (R2 = 0.238, P<0.001).